{"pageContent": "Background: Tissue biomarkers could pivotally improve clinical outcome prediction following prostate cancer therapy. Clinically, prostate cancer is managed by diverse treatment modalities whose individual influence on a biomarker's predictive ability is not well understood and poorly investigated in the literature.", "metaData": {"source": "Management of stage A prostate cancer\nhttps://pubmed.ncbi.nlm.nih.gov/2219576/"}}